Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.01 NOK | +1.78% |
|
-2.20% | -93.48% |
Jun. 24 | Ultimovacs ASA(OB:ULTI) dropped from S&P Global BMI Index | CI |
Jun. 11 | Ultimovacs Asa Provides Update from Phase I Study in Malignant Melanoma | CI |
Chart calendar Ultimovacs ASA
Upcoming events on Ultimovacs ASA
Past events on Ultimovacs ASA
2024-05-07 08:00 am | Q1 2024 Earnings Call |
2024-05-07 01:00 am | Q1 2024 Earnings Release |
2024-04-18 08:00 am | Annual General Meeting |
2024-04-17 05:00 am | Business Update Call |
2024-04-10 09:00 am | American Association for Cancer Research Meeting - Poster Board Number: 11 |
2024-04-08 01:30 pm | American Association for Cancer Research Meeting - Poster Board Number: 16 |
2024-03-07 02:00 am | INITIUM Phase II Clinical Trial Call |
2024-02-14 07:00 am | Q4 2023 Earnings Call |
2024-02-14 01:00 am | Q4 2023 Earnings Release |
2023-11-08 08:00 am | Q3 2023 Earnings Call |
2023-11-08 01:00 am | Q3 2023 Earnings Release |
2023-10-31 09:00 am | ESMO Congress |
2023-10-24 | BioStock Life Science Fall Summit |
2023-10-23 08:30 am | ESMO Congress |
2023-08-22 08:00 am | Q2 2023 Earnings Call |
2023-08-22 02:00 am | Q2 2023 Earnings Release |
2023-06-08 04:00 am | Business Update Call |
2023-06-01 12:00 am | Redeye Growth Day |
2023-05-31 12:00 am | ABGSC Life Science Summit |
2023-05-10 02:00 am | Q1 2023 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million NOK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million NOK | Released Forecast Spread | -64,2 -60,0 -6.92% | -121 -133 8.7% | -161 -150 -7.69% | -181 -189 4.24% | -213 -212 -0.59% | -153 |
EBIT Million NOK | Released Forecast Spread | -66,2 -61,5 -7.67% | -124 -136 8.58% | -164 -153 -7.31% | -184 -191 3.68% | -216 -214 -1.04% | -154 |
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -61,2 -61,0 -0.32% | -121 -135 10.88% | -165 -150 -10.17% | -168 -175 4.26% | -189 -206 8.13% | -147 |
Net income Million NOK | Released Forecast Spread | -61,2 -61,0 -0.32% | -121 -135 10.88% | -165 -150 -10.17% | -168 -175 4.25% | -189 -206 8.13% | -147 |
EPS NOK | Released Forecast Spread | -2,20 -2,19 -0.32% | -3,77 -4,23 10.88% | -5,10 -4,60 -10.99% | -4,90 -5,11 4.17% | -5,50 -6,00 8.38% | -2,40 |
Announcement Date | 14/02/20 | 17/02/21 | 17/02/22 | 16/02/23 | 14/02/24 | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Ultimovacs ASA
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ULTI Stock
- Calendar Ultimovacs ASA